Cargando…
MicroRNA-133b expression inversely correlates with MET and can serve as an optimum predictive biomarker for patients of colorectal cancer
BACKGROUND: Inactivation of the tumor suppressor gene microRNA-133b is a frequent event in various malignancies including colorectal cancer (CRC). The result of our previous research has found a statistically significant downregulation of microRNA-133b expression in human CRC cells, microRNA-133b ca...
Autores principales: | Xie, Biao, Gong, Ni, Guo, Yihang, Hu, Gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797913/ https://www.ncbi.nlm.nih.gov/pubmed/35116239 http://dx.doi.org/10.21037/tcr-20-2370 |
Ejemplares similares
-
Serum microRNA-592 serves as a novel potential biomarker for early diagnosis of colorectal cancer
por: Pan, Zhenguo, et al.
Publicado: (2020) -
Serum microRNA Profiles Serve as Novel Biomarkers for Autoimmune Diseases
por: Jin, Fangfang, et al.
Publicado: (2018) -
MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019) -
The Roles of MicroRNA-133 in Gynecological Tumors
por: Zhou, Yang, et al.
Publicado: (2022) -
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
por: Nohata, Nijiro, et al.
Publicado: (2012)